Expanding Comprehensive HIV Prevention Services for Injection Drug Users and Other Most At-Risk Populations and Maintaining Services at Muhimbili Hospital in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR | CDC RFA GH12 123904CONT16

Opportunity Information: Apply for CDC RFA GH12 123904CONT16

This funding opportunity is a continuation cooperative agreement from the U.S. Centers for Disease Control and Prevention (CDC) under the President's Emergency Plan for AIDS Relief (PEPFAR), focused on Tanzania. The full title signals two connected aims: first, expanding comprehensive HIV prevention services for injection drug users (IDUs) and other populations at particularly high risk of HIV, and second, maintaining ongoing HIV-related services at Muhimbili Hospital, a major referral and teaching hospital in the United Republic of Tanzania. The opportunity is not a new open competition; it is explicitly structured as continuation funding tied to a prior award.

The announcement is identified as CDC RFA GH12 123904CONT16 and is categorized as a continuation award, meaning the funding is intended only for organizations that were previously funded under the earlier CDC funding announcement CDC-RFA-GH12-1239 with the same program focus and title. In practical terms, this restricts eligibility to incumbent grantees already implementing the project under the original award. Because it is continuation funding, the goal is typically to sustain and build on existing program infrastructure, retain and support established service delivery platforms, and preserve progress already made with key populations rather than starting an entirely new initiative with new partners.

The funding mechanism is a cooperative agreement, which is important because it implies substantial involvement from CDC during implementation. Unlike a more hands-off grant, a cooperative agreement usually involves ongoing technical collaboration, program oversight, and joint planning between CDC and the recipient. The program sits within the health funding activity category and is listed under CFDA number 93.067, which corresponds to CDC global HIV/AIDS-related assistance under PEPFAR-era foreign assistance programming.

Programmatically, the focus on injection drug users and other most-at-risk populations reflects a prevention strategy tailored to groups that often face overlapping vulnerabilities: high exposure risk, stigma, barriers to services, and in many settings, criminalization or discrimination that pushes risk behaviors underground. "Comprehensive HIV prevention services" for IDUs commonly refers to a package approach rather than a single intervention. While the notice you provided does not spell out the service package, in PEPFAR and CDC programming this kind of language generally aligns with integrated prevention efforts such as HIV testing and counseling; linkage to antiretroviral treatment for people living with HIV; prevention counseling and risk-reduction education; sexually transmitted infection screening and treatment; condom promotion and distribution; and, in many contexts, harm reduction elements intended to reduce transmission associated with injecting practices. For other high-risk populations, comprehensive prevention similarly tends to mean layered services that combine biomedical, behavioral, and structural components, with strong referral networks and follow-up to keep people connected to care.

The mention of "maintaining services at Muhimbili Hospital" indicates that the continuation award also supports sustaining facility-based services and capacity at this specific hospital, likely because it plays a central role in specialized HIV prevention, treatment, and potentially clinical management for complicated cases or referral services. Continuation funding in this context usually helps prevent disruption in staffing, commodities, patient support systems, and program monitoring functions that can occur when funding cycles change. It also suggests a desire to keep hospital-linked services stable while expanding reach to community or key-population settings, so that prevention and care services remain connected across levels of the health system.

Administratively, the original closing date listed is November 24, 2015, and the opportunity was created on September 24, 2015. The award ceiling is shown as 0, which in many federal listings indicates that a maximum amount is not specified in the public synopsis or is controlled through internal continuation budget determinations rather than a set competitive cap. The listing notes "ExpectedAwards:" but does not provide a number, which is consistent with continuation announcements where the recipient pool is already known and the number of awards is tied to existing grants rather than open selection. The eligible applicants field is summarized as "Others," but the narrative restriction is the controlling detail: only prior grantees under the named earlier announcement are intended to receive continuation funds.

In short, this CDC/PEPFAR opportunity is best understood as a bridge or renewal-style action for an existing Tanzania HIV prevention and service maintenance program. It is designed to keep proven operations running and to extend comprehensive prevention coverage for injection drug users and other populations at highest risk, while ensuring that key facility-based services at Muhimbili Hospital remain in place and functional under continued CDC technical partnership.

• The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Expanding Comprehensive HIV Prevention Services for Injection Drug Users and Other Most At-Risk Populations and Maintaining Services at Muhimbili Hospital in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on 2015-09-24.
• Applicants must submit their applications by 2015-11-24. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: Others.

Apply for CDC RFA GH12 123904CONT16

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: